How blood cancer research might help organ transplant patients

Loading

Fred Hutch study suggests certain immune cells are source of antibodies that attack donated organs

Each day, 13 patients awaiting transplants for severe kidney disease in the U.S. lose their lives before a compatible kidney can be found.

Frequently, it is simply that there are not enough donated organs available, but sometimes it is because the right donor is too rare. Of the 92,000 people in U.S. waiting this year for a kidney transplant, about one in ten will have an especially hard time finding a compatible donor. Read more from the Fred Hutch News Service.

Loading

Pioneering protocol could enable transplant recipients to thrive without antirejection drugs

Loading

Performing human-organ transplants without the necessity for a lifetime regimen of immunosuppressive drugs has been an enduring goal for transplantation medicine.

Now, a new protocol being implemented at UCLA Health with select living-donor kidney-transplant patients is bringing that dream closer to reality.

“It is the Holy Grail,” says renal transplant surgeon Jeffrey Veale, MD, who has led the pioneering effort to develop the protocol. Read more.

Loading